To address these questions, in the present study, we employ Hmgcs2 loss- and gain-of-function mouse models to investigate a causal relationship of deficient and active ketogenesis in NAFLD development and treatment, respectively. Here, HMGCS2 is linked to metabolic dysfunction-associated steatotic liver disease.